{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:56:43Z","timestamp":1781211403325,"version":"3.54.1"},"reference-count":127,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"ICW Healthcare Ventures"},{"name":"Merck Research Laboratories"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.mayocp.2020.07.021","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T12:10:16Z","timestamp":1596111016000},"page":"2172-2188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["SARS-CoV-2 Vaccine Development: Current Status"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5057-4457","authenticated-orcid":false,"given":"Gregory A.","family":"Poland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna G.","family":"Ovsyannikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen N.","family":"Crooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mayocp.2020.07.021_bib1","doi-asserted-by":"crossref","first-page":"108693","DOI":"10.1016\/j.vetmic.2020.108693","article-title":"Novel human coronavirus (SARS-CoV-2): a lesson from animal coronaviruses","volume":"244","author":"Decaro","year":"2020","journal-title":"Vet Microbiol"},{"issue":"10223","key":"10.1016\/j.mayocp.2020.07.021_bib3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A\u00a0familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.mayocp.2020.07.021_bib4","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mayocp.2020.07.021_bib5","doi-asserted-by":"crossref","first-page":"2000044","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000044","article-title":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020","volume":"25","author":"Wu","year":"2020","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.mayocp.2020.07.021_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan [published correction appears in Emerg Microbes Infect. 2020;9(1):540]","volume":"9","author":"Chan","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"3","key":"10.1016\/j.mayocp.2020.07.021_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.mayocp.2020.07.021_bib8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1473-3099(20)30250-4","article-title":"SARS-CoV-2: a time for clear and immediate action","volume":"20","author":"Poland","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"18","key":"10.1016\/j.mayocp.2020.07.021_bib9","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.mayocp.2020.07.021_bib10","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S1473-3099(20)30147-X","article-title":"A\u00a0family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China","volume":"20","author":"Huang","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.mayocp.2020.07.021_bib11","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3201\/eid2607.200839","article-title":"Severe acute respiratory syndrome coronavirus 2 RNA detected in blood donations","volume":"26","author":"Chang","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"10223","key":"10.1016\/j.mayocp.2020.07.021_bib12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mayocp.2020.07.021_bib13","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1016\/j.vaccine.2020.04.073","article-title":"Tortoises, hares, and vaccines: a cautionary note for SARS-CoV-2 vaccine development [editorial]","volume":"38","author":"Poland","year":"2020","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.mayocp.2020.07.021_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J\u00a0Virol"},{"issue":"2","key":"10.1016\/j.mayocp.2020.07.021_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.mayocp.2020.07.021_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2020.03.044","article-title":"Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses","volume":"526","author":"Qi","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.mayocp.2020.07.021_bib17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.mayocp.2020.07.021_bib18","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1128\/JVI.00128-13","article-title":"The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies","volume":"87","author":"Gierer","year":"2013","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.mayocp.2020.07.021_bib19","author":"Wang"},{"issue":"3","key":"10.1016\/j.mayocp.2020.07.021_bib20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.humpath.2004.11.006","article-title":"Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan","volume":"36","author":"Shieh","year":"2005","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.mayocp.2020.07.021_bib21","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1128\/JVI.78.7.3572-3577.2004","article-title":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice","volume":"78","author":"Subbarao","year":"2004","journal-title":"J\u00a0Virol"},{"issue":"10223","key":"10.1016\/j.mayocp.2020.07.021_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020;395(10223):496]","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mayocp.2020.07.021_bib23","author":"Choudhury"},{"issue":"5","key":"10.1016\/j.mayocp.2020.07.021_bib24","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features in severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.mayocp.2020.07.021_bib25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41591-020-0819-2","article-title":"Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19","volume":"26","author":"Thevarajan","year":"2020","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.mayocp.2020.07.021_bib26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","article-title":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mayocp.2020.07.021_bib27","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fmicb.2020.00298","article-title":"Subunit vaccines against emerging pathogenic human coronaviruses","volume":"11","author":"Wang","year":"2020","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.mayocp.2020.07.021_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/v11010059","article-title":"From SARS to MERS, thrusting coronaviruses into the spotlight","volume":"11","author":"Song","year":"2019","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.mayocp.2020.07.021_bib29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/22221751.2020.1725399","article-title":"RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak","volume":"9","author":"Chen","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"17","key":"10.1016\/j.mayocp.2020.07.021_bib30","doi-asserted-by":"crossref","first-page":"9241","DOI":"10.1073\/pnas.2004999117","article-title":"Phylogenetic network analysis of SARS-CoV-2 genomes","volume":"117","author":"Forster","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.mayocp.2020.07.021_bib31","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1080\/22221751.2020.1773745","article-title":"Genetic cluster analysis of SARS-CoV-2 and the identification of those responsible for the major outbreaks in various countries","volume":"9","author":"Yang","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.mayocp.2020.07.021_bib32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2148-4-21","article-title":"Moderate mutation rate in the SARS coronavirus genome and its implications","volume":"4","author":"Zhao","year":"2004","journal-title":"BMC Evol Biol"},{"issue":"1","key":"10.1016\/j.mayocp.2020.07.021_bib33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/viro.1996.0519","article-title":"Genetic variation in neuraminidase genes of influenza A (H3N2) viruses","volume":"224","author":"Xu","year":"1996","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.mayocp.2020.07.021_bib34","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1128\/JVI.02389-06","article-title":"Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus","volume":"81","author":"Liu","year":"2007","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.mayocp.2020.07.021_bib35","first-page":"410","article-title":"Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: an in silico analysis","volume":"19","author":"Ortega","year":"2020","journal-title":"EXCLI J"},{"key":"10.1016\/j.mayocp.2020.07.021_bib36","author":"Ou"},{"key":"10.1016\/j.mayocp.2020.07.021_bib37","author":"Ou"},{"key":"10.1016\/j.mayocp.2020.07.021_bib38","author":"Korber"},{"key":"10.1016\/j.mayocp.2020.07.021_bib39","author":"Daniloski"},{"key":"10.1016\/j.mayocp.2020.07.021_bib40","author":"Zhang"},{"key":"10.1016\/j.mayocp.2020.07.021_bib41","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ijid.2020.05.071","article-title":"Could the D614G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality?","volume":"96","author":"Eaaswarkhanth","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.mayocp.2020.07.021_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: an overview of their replication and pathogenesis","volume":"1282","author":"Fehr","year":"2015","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1016\/j.mayocp.2020.07.021_bib43","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1128\/JVI.02699-12","article-title":"The acetyl-esterase activity of the hemagglutinin-esterase protein of human coronavirus OC43 strongly enhances the production of infectious virus","volume":"87","author":"Desforges","year":"2013","journal-title":"J\u00a0Virol"},{"issue":"14","key":"10.1016\/j.mayocp.2020.07.021_bib44","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1128\/JVI.02744-05","article-title":"Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain","volume":"80","author":"Li","year":"2006","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.mayocp.2020.07.021_bib45","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1038\/ncomms4067","article-title":"Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor","volume":"5","author":"Lu","year":"2014","journal-title":"Nat Commun"},{"issue":"6491","key":"10.1016\/j.mayocp.2020.07.021_bib46","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.abb7269","article-title":"A\u00a0highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"Yuan","year":"2020","journal-title":"Science"},{"issue":"6494","key":"10.1016\/j.mayocp.2020.07.021_bib49","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1126\/science.abc5312","article-title":"A\u00a0strategic approach to COVID-19 vaccine R&D","volume":"368","author":"Corey","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.mayocp.2020.07.021_bib50","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/22221751.2019.1624482","article-title":"Antibodies and vaccines against Middle East respiratory syndrome coronavirus","volume":"8","author":"Xu","year":"2019","journal-title":"Emerg Microbes Infect"},{"issue":"26","key":"10.1016\/j.mayocp.2020.07.021_bib51","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.vaccine.2014.04.016","article-title":"Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice","volume":"32","author":"Coleman","year":"2014","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.mayocp.2020.07.021_bib52","doi-asserted-by":"crossref","first-page":"9939","DOI":"10.1128\/JVI.01048-13","article-title":"Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development [published correction appears in J Virol. 2013;87(21):11963]","volume":"87","author":"Du","year":"2013","journal-title":"J\u00a0Virol"},{"issue":"12","key":"10.1016\/j.mayocp.2020.07.021_bib53","doi-asserted-by":"crossref","first-page":"e81587","DOI":"10.1371\/journal.pone.0081587","article-title":"A\u00a0truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines","volume":"8","author":"Du","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.mayocp.2020.07.021_bib54","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.4049\/jimmunol.174.8.4908","article-title":"Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies","volume":"174","author":"He","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.mayocp.2020.07.021_bib55","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41541-017-0029-1","article-title":"Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model","volume":"2","author":"Munster","year":"2017","journal-title":"NPJ Vaccines"},{"issue":"301","key":"10.1016\/j.mayocp.2020.07.021_bib56","doi-asserted-by":"crossref","first-page":"301ra132","DOI":"10.1126\/scitranslmed.aac7462","article-title":"A\u00a0synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates","volume":"7","author":"Muthumani","year":"2015","journal-title":"Sci Transl Med"},{"issue":"6268","key":"10.1016\/j.mayocp.2020.07.021_bib57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.aad1283","article-title":"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels","volume":"351","author":"Haagmans","year":"2016","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.mayocp.2020.07.021_bib58","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1073\/pnas.1323279111","article-title":"Rapid generation of a mouse model for Middle East respiratory syndrome","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"10.1016\/j.mayocp.2020.07.021_bib59","doi-asserted-by":"crossref","first-page":"9318","DOI":"10.1128\/JVI.01049-10","article-title":"T\u00a0cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice","volume":"84","author":"Zhao","year":"2010","journal-title":"J\u00a0Virol"},{"issue":"10","key":"10.1016\/j.mayocp.2020.07.021_bib60","doi-asserted-by":"crossref","first-page":"e1000636","DOI":"10.1371\/journal.ppat.1000636","article-title":"Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice","volume":"5","author":"Zhao","year":"2009","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.mayocp.2020.07.021_bib61","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/acsinfecdis.6b00006","article-title":"Immunodominant SARS coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non-human primates [published correction appears in ACS Infect Dis. 2020;6(5):1284-1285]","volume":"2","author":"Wang","year":"2016","journal-title":"ACS Infect Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2020.07.021_bib62","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbrc.2014.07.090","article-title":"Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins","volume":"451","author":"Wang","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mayocp.2020.07.021_bib63","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1743-422X-11-82","article-title":"Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus","volume":"11","author":"Yip","year":"2014","journal-title":"Virol J"},{"issue":"20","key":"10.1016\/j.mayocp.2020.07.021_bib64","doi-asserted-by":"crossref","first-page":"10582","DOI":"10.1128\/JVI.00671-11","article-title":"Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent Fc\u03b3R pathway","volume":"85","author":"Jaume","year":"2011","journal-title":"J\u00a0Virol"},{"issue":"23","key":"10.1016\/j.mayocp.2020.07.021_bib65","doi-asserted-by":"crossref","first-page":"12201","DOI":"10.1128\/JVI.06048-11","article-title":"A\u00a0double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge","volume":"85","author":"Bolles","year":"2011","journal-title":"J\u00a0Virol"},{"issue":"22","key":"10.1016\/j.mayocp.2020.07.021_bib66","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.1128\/JVI.78.22.12672-12676.2004","article-title":"Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets","volume":"78","author":"Weingartl","year":"2004","journal-title":"J\u00a0Virol"},{"issue":"9","key":"10.1016\/j.mayocp.2020.07.021_bib67","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1080\/21645515.2016.1177688","article-title":"Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus","volume":"12","author":"Agrawal","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"17-18","key":"10.1016\/j.mayocp.2020.07.021_bib68","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.vaccine.2005.01.033","article-title":"Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets","volume":"23","author":"Czub","year":"2005","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.mayocp.2020.07.021_bib69","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nri1732","article-title":"Immunopathogenesis of coronavirus infections: implications for SARS","volume":"5","author":"Perlman","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"6494","key":"10.1016\/j.mayocp.2020.07.021_bib70","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.abb8923","article-title":"Rapid COVID-19 vaccine development","volume":"368","author":"Graham","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.mayocp.2020.07.021_bib71","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.mayocp.2020.07.021_bib72","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1074\/jbc.C300520200","article-title":"A\u00a0193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2","volume":"279","author":"Wong","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.mayocp.2020.07.021_bib73","author":"Jiang"},{"issue":"7","key":"10.1016\/j.mayocp.2020.07.021_bib74","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3201\/eid2607.200841","article-title":"Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease patients","volume":"26","author":"Okba","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2020.07.021_bib75","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.immuni.2020.04.023","article-title":"Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals","volume":"52","author":"Ni","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.mayocp.2020.07.021_bib76","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cca.2020.04.026","article-title":"IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: a longitudinal study","volume":"507","author":"Padoan","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.mayocp.2020.07.021_bib77","author":"Kuri-Cervantes"},{"key":"10.1016\/j.mayocp.2020.07.021_bib78","author":"Braun"},{"issue":"7","key":"10.1016\/j.mayocp.2020.07.021_bib79","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.mayocp.2020.07.021_bib80","author":"Peng"},{"issue":"10240","key":"10.1016\/j.mayocp.2020.07.021_bib81","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","article-title":"Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial","volume":"395","author":"Zhu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mayocp.2020.07.021_bib82","author":"Neidleman"},{"key":"10.1016\/j.mayocp.2020.07.021_bib83","author":"Juno"},{"key":"10.1016\/j.mayocp.2020.07.021_bib84","author":"Sekine"},{"issue":"1-2","key":"10.1016\/j.mayocp.2020.07.021_bib85","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jim.2010.10.011","article-title":"Prediction of epitopes using neural network based methods","volume":"374","author":"Lundegaard","year":"2011","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.mayocp.2020.07.021_bib86","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-1-4939-1115-8_12","article-title":"Machine learning-based methods for prediction of linear B-cell epitopes","volume":"1184","author":"Wang","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.mayocp.2020.07.021_bib87","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1471-2105-8-238","article-title":"Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method","volume":"8","author":"Nielsen","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.mayocp.2020.07.021_bib88","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/1471-2105-8-424","article-title":"Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction","volume":"8","author":"Larsen","year":"2007","journal-title":"BMC Bioinformatics"},{"issue":"8","key":"10.1016\/j.mayocp.2020.07.021_bib89","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1002\/eji.200425811","article-title":"An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions","volume":"35","author":"Larsen","year":"2005","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.mayocp.2020.07.021_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00251-008-0341-z","article-title":"NetMHCpan, a method for MHC class I binding prediction beyond humans","volume":"61","author":"Hoof","year":"2009","journal-title":"Immunogenetics"},{"issue":"9","key":"10.1016\/j.mayocp.2020.07.021_bib91","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","article-title":"NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data","volume":"199","author":"Jurtz","year":"2017","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.mayocp.2020.07.021_bib92","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/imm.12889","article-title":"Improved methods for predicting peptide binding affinity to MHC class II molecules","volume":"154","author":"Jensen","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.mayocp.2020.07.021_bib93","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-7580-2-2","article-title":"Improved method for predicting linear B-cell epitopes","volume":"2","author":"Larsen","year":"2006","journal-title":"Immunome Res"},{"issue":"11","key":"10.1016\/j.mayocp.2020.07.021_bib94","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1110\/ps.062405906","article-title":"Prediction of residues in discontinuous B-cell epitopes using protein 3D structures","volume":"15","author":"Haste Andersen","year":"2006","journal-title":"Protein Sci"},{"issue":"1","key":"10.1016\/j.mayocp.2020.07.021_bib95","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.vaccine.2009.09.126","article-title":"Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development","volume":"28","author":"Johnson","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.mayocp.2020.07.021_bib96","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12967-019-2116-8","article-title":"Epitope-based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study","volume":"17","author":"Tahir Ul Qamar","year":"2019","journal-title":"J\u00a0Transl Med"},{"issue":"12","key":"10.1016\/j.mayocp.2020.07.021_bib97","doi-asserted-by":"crossref","first-page":"e0144475","DOI":"10.1371\/journal.pone.0144475","article-title":"Epitope-based vaccine target screening against highly pathogenic MERS-CoV: an in silico approach applied to emerging infectious diseases","volume":"10","author":"Shi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mayocp.2020.07.021_bib98","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.2147\/IDR.S175114","article-title":"Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach","volume":"11","author":"Srivastava","year":"2018","journal-title":"Infect Drug Resist"},{"issue":"1","key":"10.1016\/j.mayocp.2020.07.021_bib99","doi-asserted-by":"crossref","first-page":"14179","DOI":"10.1038\/s41598-020-70864-8","article-title":"Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome","volume":"10","author":"Crooke","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.mayocp.2020.07.021_bib100","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.chom.2020.03.002","article-title":"A\u00a0sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2","volume":"27","author":"Grifoni","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"5","key":"10.1016\/j.mayocp.2020.07.021_bib101","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/jmv.25698","article-title":"Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV","volume":"92","author":"Baruah","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.mayocp.2020.07.021_bib102","doi-asserted-by":"crossref","first-page":"112787","DOI":"10.1016\/j.jim.2020.112787","article-title":"In the search of potential epitopes for Wuhan seafood market pneumonia virus using high order nullomers","volume":"481-482","author":"Santoni","year":"2020","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.mayocp.2020.07.021_bib103","doi-asserted-by":"crossref","first-page":"145","DOI":"10.12688\/f1000research.22507.2","article-title":"In silico identification of vaccine targets for 2019-nCoV","volume":"9","author":"Lee","year":"2020","journal-title":"F1000Res"},{"issue":"13","key":"10.1016\/j.mayocp.2020.07.021_bib104","doi-asserted-by":"crossref","first-page":"e00510","DOI":"10.1128\/JVI.00510-20","article-title":"Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2","volume":"94","author":"Nguyen","year":"2020","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.mayocp.2020.07.021_bib105","author":"Campbell"},{"key":"10.1016\/j.mayocp.2020.07.021_bib106","author":"Enayatkhani"},{"issue":"6","key":"10.1016\/j.mayocp.2020.07.021_bib107","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/jmv.25736","article-title":"Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): immunoinformatics approach","volume":"92","author":"Bhattacharya","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.mayocp.2020.07.021_bib108","author":"Jakhar"},{"key":"10.1016\/j.mayocp.2020.07.021_bib109","author":"Jackson"},{"key":"10.1016\/j.mayocp.2020.07.021_bib110","author":"Chen"},{"issue":"4","key":"10.1016\/j.mayocp.2020.07.021_bib111","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.immuni.2020.03.007","article-title":"SARS-CoV-2 vaccines: status report","volume":"52","author":"Amanat","year":"2020","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.mayocp.2020.07.021_bib112","first-page":"623","article-title":"Potential rapid diagnostics, vaccine and therapeutics for 2019 novel coronavirus (2019-nCoV): a systematic review","volume":"9","author":"Pang","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"14","key":"10.1016\/j.mayocp.2020.07.021_bib113","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1016\/j.vaccine.2020.02.056","article-title":"A\u00a0codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates","volume":"38","author":"Mueller","year":"2020","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.mayocp.2020.07.021_bib114","doi-asserted-by":"crossref","first-page":"e0223784","DOI":"10.1371\/journal.pone.0223784","article-title":"Live-attenuated H1N1 influenza vaccine candidate displays potent efficacy in mice and ferrets","volume":"14","author":"Stauft","year":"2019","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.mayocp.2020.07.021_bib115","doi-asserted-by":"crossref","first-page":"e0198303","DOI":"10.1371\/journal.pone.0198303","article-title":"Extensive recoding of dengue virus type 2 specifically reduces replication in primate cells without gain-of-function in Aedes aegypti mosquitoes","volume":"13","author":"Stauft","year":"2018","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.mayocp.2020.07.021_bib116","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1016\/j.vaccine.2006.01.058","article-title":"Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates","volume":"24","author":"Liu","year":"2006","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.mayocp.2020.07.021_bib117","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1016\/j.vaccine.2009.05.073","article-title":"Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice","volume":"27","author":"Zheng","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.mayocp.2020.07.021_bib118","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/pathogens9020148","article-title":"Emergence of novel coronavirus 2019-nCoV: need for rapid vaccine and biologics development","volume":"9","author":"Shanmugaraj","year":"2020","journal-title":"Pathogens"},{"issue":"16","key":"10.1016\/j.mayocp.2020.07.021_bib119","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.vaccine.2016.02.033","article-title":"Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola\/Makona virus glycoprotein (GP) nanoparticle vaccine in mice","volume":"34","author":"Bengtsson","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.mayocp.2020.07.021_bib120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12026-018-8991-x","article-title":"Matrix-M\u2122 adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice","volume":"66","author":"Magnusson","year":"2018","journal-title":"Immunol Res"},{"issue":"1","key":"10.1016\/j.mayocp.2020.07.021_bib123","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/vim.2011.0050","article-title":"Immune responses to mucosal vaccination by the recombinant A1 and N proteins of infectious bronchitis virus","volume":"25","author":"Meir","year":"2012","journal-title":"Viral Immunol"},{"issue":"6","key":"10.1016\/j.mayocp.2020.07.021_bib124","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/sj.clpt.6100389","article-title":"Mass spectrometry and peptide-based vaccine development","volume":"82","author":"Ovsyannikova","year":"2007","journal-title":"Clin Pharmacol.Ther"},{"issue":"1","key":"10.1016\/j.mayocp.2020.07.021_bib125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1128\/JVI.78.1.42-51.2004","article-title":"Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides","volume":"78","author":"Ovsyannikova","year":"2004","journal-title":"J\u00a0Virol"},{"issue":"6","key":"10.1016\/j.mayocp.2020.07.021_bib126","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1021\/pr0501416","article-title":"Identification of class II HLA-DRB1\u221703-bound measles virus peptides by 2D-liquid chromatography tandem mass spectrometry","volume":"4","author":"Johnson","year":"2005","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.mayocp.2020.07.021_bib127","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0042-6822(03)00281-2","article-title":"Naturally processed measles virus peptide eluted from class II HLA-DRB1\u221703 recognized by T lymphocytes from human blood","volume":"312","author":"Ovsyannikova","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.mayocp.2020.07.021_bib128","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.smim.2017.08.014","article-title":"Major findings and recent advances in virus-like particle (VLP)-based vaccines","volume":"34","author":"Mohsen","year":"2017","journal-title":"Semin Immunol"},{"key":"10.1016\/j.mayocp.2020.07.021_bib129","doi-asserted-by":"crossref","first-page":"102743","DOI":"10.1016\/j.ebiom.2020.102743","article-title":"Microneedle array delivered recombinant coronavirus vaccines: immunogenicity and rapid translational development","volume":"55","author":"Kim","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mayocp.2020.07.021_bib132","author":"Mulligan"},{"issue":"5","key":"10.1016\/j.mayocp.2020.07.021_bib133","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.4049\/jimmunol.103.5.1089","article-title":"Serologic classification of chimpanzee adenoviruses by hemagglutination and hemagglutination inhibition","volume":"103","author":"Hillis","year":"1969","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.mayocp.2020.07.021_bib134","author":"Kirka"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620308272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620308272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:34:40Z","timestamp":1758418480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619620308272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":127,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0025619620308272"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.07.021","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 Vaccine Development: Current Status","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}